Plato BioPharma Presenting Preclinical capabilities at PKPD Summit Boston - WALB.com, Albany News, Weather, Sports

Plato BioPharma Presenting Preclinical capabilities at PKPD Summit Boston

  • More WALB News10 HeadlinesMore News Headlines

  • Wednesday, May 22 2013 5:17 PM EDT2013-05-22 21:17:14 GMT
    Right now, American Red Cross volunteers are at work in Oklahoma staffing shelters and serving meals and helping tornado survivors put their lives back together. We all know the Red Cross is there during
    We all know the Red Cross is there during big disasters like the tornado in Oklahoma. But the emergency to which they respond most is a house fire, and they desperately need volunteers to help.

  • Wednesday, May 22 2013 5:02 PM EDT2013-05-22 21:02:02 GMT
    The Albany Police Depart is engaged in a recruitment campaign to get its officer corps up to full strength. APD is budgeted for 214 officers, and right now is about 20 officers short of that level, and
    The Albany Police Depart is engaged in a recruitment campaign to get its officer corps up to full strength. APD offers the training program for people who do not already have POST certification. Starting salary for a rookie officer is over $33,000 annually.

  • Wednesday, May 22 2013 4:55 PM EDT2013-05-22 20:55:33 GMT
    The city has settled a lawsuit over more than $2 million in unpaid federal loans owed by the owners of Albany Heights. City attorney Nathan Davis announced that the city had accepted a deed and $110,000

    The city has settled a lawsuit over more than $2 million in unpaid federal loans owed by the owners of Albany Heights.

    •   

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE Plato BioPharma, Inc.

WESTMINSTER, Colo., March 19, 2013 /PRNewswire/ -- Plato BioPharma, Inc. (PBI) will be presenting their integrated pharmacology capabilities at the "PKPD Summit Boston" in Boston, Massachusetts on March 20, 2013.  The presentation will overview PBI's integrated pharmacology approach.  The presentation will be delivered by Drs. Glenn J. Smits, PhD and Craig F. Plato, PhD, President of Plato BioPharma, Inc.

"Clients trust PBI to deliver complex preclinical proof of concept studies due to our extensive industry experience in disease modeling and discovery pharmacology.  We're participating in the PKPD Summit to detail our broader capabilities and expertise in drug discovery.  We appreciate the challenges of translating preclinical work, and believe PBI is well-positioned to address these challenges and provide disease-relevant PK and PD approaches.  We strive to bring a more creative and partnering approach to the preclinical paradigm to deliver the highest quality science while decreasing the time for enabling decisions thus minimizing cost," said Dr. Plato.

Founded in 2009, Plato BioPharma, Inc. is a leading preclinical contract research organization (CRO).  The company offers expert drug discovery and development capabilities in cardiovascular, renal, pulmonary, and hepatic disease therapeutic areas.  PBI provides an integrated research platform from the in-life phase through clinical chemistry, biomarker and histological analyses.  The company specializes in custom study design and execution of engagements ranging from pharmacokinetics through disease model development and proof-of-concept evaluation.  PBI is headquartered in Westminster, Colorado.

Contact: Bob Leahy
Phone: 303-506-6960
Email: bleahy@platobiopharma.com
Website: www.platobiopharma.com

©2012 PR Newswire. All Rights Reserved.